Development of a cost-effectiveness analysis model for Duchenne muscular dystrophy utilizing the national registry in Japan. [PDF]
Okada T +5 more
europepmc +1 more source
Diagnostic Precision in Pediatric Neuromuscular Disorders: A Case Study of Bethlem Myopathy Mimicking Duchenne Muscular Dystrophy. [PDF]
Alyami NH +5 more
europepmc +1 more source
Correction: The rise of rat models for Duchenne muscular dystrophy and therapeutic evaluations. [PDF]
Relaix F +3 more
europepmc +1 more source
Correction: Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy. [PDF]
Beekman C +4 more
europepmc +1 more source
Myofibre Density Reveals a Critical Threshold Around Age 6 in Steroid-Naïve Duchenne Muscular Dystrophy: A Retrospective Observational Study. [PDF]
Yamakado T +10 more
europepmc +1 more source
Implications for Cardiac Function Following Rescue of the Dystrophic Diaphragm in a Mouse Model of Duchenne Muscular Dystrophy [PDF]
A Asai +37 more
core +1 more source
Real-world experience with gene therapy in Duchenne muscular dystrophy center readiness and patients safety: report from Qatar. [PDF]
Osman MF +6 more
europepmc +1 more source
Functional and structural pathologies in skeletal muscle of a rat model of Duchenne muscular dystrophy. [PDF]
Lee YI +7 more
europepmc +1 more source
Beta-nicotinamide mononucleotide attenuates creatine kinase release in Duchenne muscular dystrophy model rats. [PDF]
Nakamura K +9 more
europepmc +1 more source

